Jan Östergren

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jan Östergren är professor emeritus i medicin. Hans forskning handlar framför allt om angiologi, det vill säga vaskulär medicin och hypertoni/högt blodtryck.

Artiklar

Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2023;57(1):2236341
Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation
Klaveback S; Skuladottir H; Olbers J; Ostergren J; Braunschweig F
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. HYPERTENSION. 2021;8:100074
Ambulatory blood pressure monitoring and blood pressure control in patients with coronary artery disease-A randomized controlled trial
Hagglund O; Svensson P; Linde C; Ostergren J
Article: JOURNAL OF HYPERTENSION. 2021;39(2):243-249
Changes in 24-h ambulatory blood pressure following restoration of sinus rhythmin patients with atrial fibrillation
Olbers J; Ostergren J; Rosenqvist M; Skuladottir H; Klaveback S; Ljungman P; Witt N
Article: ANNALS OF EMERGENCY MEDICINE. 2019;74(3):345-356
Associations Between Crowding and Ten-Day Mortality Among Patients Allocated Lower Triage Acuity Levels Without Need of Acute Hospital Care on Departure From the Emergency Department
Berg LM; Ehrenberg A; Florin J; Ostergren J; Discacciati A; Goransson KE
Article: JMIR MEDICAL EDUCATION. 2019;5(2):e12791
Why Medical Students Choose to Use or Not to Use a Web-Based Electrocardiogram Learning Resource: Mixed Methods Study.
Nilsson M; Fors U; Östergren J; Bolinder G; Edelbring S
Article: INTERNATIONAL EMERGENCY NURSING. 2019;43:50-55
Significant changes in emergency department length of stay and case mix over eight years at a large Swedish University Hospital
Berg LM; Ehrenberg A; Florin J; Ostergren J; Goransson KE
Article: THE JOURNAL OF CLINICAL HYPERTENSION. 2019;21(3):363-368
Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion
Olbers J; Jacobson E; Viberg F; Witt N; Ljungman P; Rosenqvist M; Ostergren J
Article: BLOOD PRESSURE. 2018;27(5):249-255
High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm
Olbers J; Gille A; Ljungman P; Rosenqvist M; Ostergren J; Witt N
Article: INTERNATIONAL EMERGENCY NURSING. 2017;33:14-19
Physicians' and nurses' perceptions of patient safety risks in the emergency department
Kallberg A-S; Ehrenberg A; Florin J; Ostergren J; Goransson KE
Article: NEONATOLOGY. 2017;112(1):87-91
Retinopathy of Prematurity Is Associated with Increased Systolic Blood Pressure in Adults Who Were Born Preterm
Kistner A; Jacobson L; Ostergren J; Hellstrom A
Article: INTERNATIONAL EMERGENCY NURSING. 2016;29:21-26
Reasons for interrupting colleagues during emergency department work - A qualitative study
Berg LM; Florin J; Ehrenberg A; Ostergren J; Djarv T; Goransson KE
Article: BLOOD PRESSURE. 2016;25(5):286-291
Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease
Hagglund O; Sjoqvist I; Linde C; Svensson P; Ostergren J
Article: INTERNATIONAL EMERGENCY NURSING. 2016;27:11-16
Factors influencing clinicians' perceptions of interruptions as disturbing or non-disturbing: A qualitative study
Berg LM; Kallberg A-S; Ehrenberg A; Florin J; Ostergren J; Djarv T; Brixey JJ; Goransson KE
Journal article: CIRCULATION. 2015;132(suppl_3)
Abstract 16891: Beat-to-beat Systolic as Well as Diastolic Blood Pressure Variability is High in Atrial Fibrillation
Olbers J; Gille A; Östergren J; Ljungman P; Rosenqvist M; Witt N
Article: INTERNATIONAL EMERGENCY NURSING. 2015;23(2):156-161
Contributing factors to errors in Swedish emergency departments
Kallberg A-S; Goransson KE; Florin J; Ostergren J; Brixey JJ; Ehrenberg A
Article: THE JOURNAL OF CLINICAL HYPERTENSION. 2015;17(2):141-146
Amlodipine plus Benazepril is Superior to Hydrochlorothiazide plus Benazepril Irrespective of Baseline Pulse Pressure: Subanalysis of the ACCOMPLISH Trial
Skoglund PH; Svensson P; Asp J; Dahlof B; Kjeldsen SE; Jamerson KA; Weber MA; Jia Y; Zappe DH; Ostergren J
Article: DIABETES AND VASCULAR DISEASE RESEARCH. 2014;11(3):133-173
ESC Guidelines on diabetes, pre- diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary
Ryden L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Sousa M; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Luis Zamorano J; Luis Zamorano J; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Luis Tamargo J; Tendera M; Torbicki A; Wijns W; Windecker S; De Backer G; Sirnes PA; Alegria Ezquerra E; Avogaro A; Badimon L; Baranova E; Baumgartner H; Betteridge J; Ceriello A; Fagard R; Funck-Brentano C; Gulba DC; Hasdai D; Hoes AW; Kjekshus JK; Knuuti J; Kolh P; Lev E; Mueller C; Neyses L; Nilsson PM; Perk J; Ponikowski P; Reiner Z; Sattar N; Schaechinger V; Scheen A; Schirmer H; Stromberg A; Sudzhaeva S; Luis Tamargo J; Viigimaa M; Vlachopoulos C; Xuereb RG
Article: AMERICAN JOURNAL OF HYPERTENSION. 2014;27(3):363-371
Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein but Not Cystatin C Predict Cardiovascular Events in Male Patients with Peripheral Artery Disease Independently of Ambulatory Pulse Pressure
Skoglund PH; Arpegard J; Ostergren J; Svensson P
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2014;16(1):33-40
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
Rogers JK; Pocock SJ; McMurray JJV; Granger CB; Michelson EL; Ostergren J; Pfeffer MA; Solomon SD; Swedberg K; Yusuf S
Article: EUROPEAN HEART JOURNAL. 2013;34(39):3035-3087
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Ryden L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
Article: BMJ QUALITY AND SAFETY. 2013;22(8):656-663
Interruptions in emergency department work: an observational and interview study
Berg LM; Kallberg A-S; Goransson KE; Ostergren J; Florin J; Ehrenberg A
Article: JOURNAL OF HYPERTENSION. 2013;31(7):1281-1357
2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC)
Mancia G; Fagard R; Narkiewicz K; Redon J; Zanchetti A; Boehm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Redon J; Dominiczak A; Narkiewicz K; Nilsson PM; Burnier M; Viigimaa M; Ambrosioni E; Caufield M; Coca A; Olsen MH; Schmieder RE; Tsioufis C; van de Borne P; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Fagard DH; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Clement DL; Coca A; Gillebert TC; Tendera M; Rosei EA; Ambrosioni E; Anker SD; Bauersachs J; Hitij JB; Caulfield M; De Buyzere M; De Geest S; Derumeaux GA; Erdine S; Farsang C; Funck-Brentano C; Gerc V; Germano G; Gielen S; Haller H; Hoes AW; Jordan J; Kahan T; Komajda M; Lovic D; Mahrholdt H; Olsen MH; Ostergren J; Parati G; Perk J; Polonia J; Popescu BA; Reiner Z; Ryden L; Sirenko Y; Stanton A; Struijker-Boudier H; Tsioufis C; van de Borne P; Vlachopoulos C; Volpe M; Wood DA
Article: EUROPEAN JOURNAL OF EMERGENCY MEDICINE. 2013;20(1):33-38
Medical errors and complaints in emergency department care in Sweden as reported by care providers, healthcare staff, and patients - a national review
Kallberg A-S; Goransson KE; Ostergren J; Florin J; Ehrenberg A
Article: KARDIOLOGIA POLSKA. 2013;71:S319-S394
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Ryden L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
Article: EUROPEAN JOURNAL OF EMERGENCY MEDICINE. 2012;19(4):246-251
An observational study of activities and multitasking performed by clinicians in two Swedish emergency departments
Berg LM; Ehrenberg A; Florin J; Ostergren J; Goransson KE
Article: BLOOD PRESSURE. 2012;21(4):227-232
Ambulatory pulse pressure predicts cardiovascular events in patients with peripheral arterial disease
Skoglund PH; Ostergren J; Svensson P
Article: ANNALS OF MEDICINE. 2012;44(3):262-270
Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease
Holzmann MJ; Jungner I; Walldius G; Ivert T; Nordqvist T; Ostergren J; Hammar N
Article: BLOOD PRESSURE. 2012;21(2):82-87
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study
Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlof B; Velazquez EJ; Hua TA; Kelly RY; Zappe D; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M
Article: TÜRK KARDIYOLOJI DERNEĞI ARŞIVI. 2012;40 Suppl 1:5-60
[ESC guidelines for the treatment and diagnosis of peripheral artery disease. Guideline includes extracranial carotid artery, vertebral, mesenteric, renal, upper and lower extremity arteries].
Tendera M; Aboyans V; Bartelink L; Baumgartner I; Clement D; Collet J-P; Cremonesi A; De Carlo M; Erbel R; Fowkes FGR; Heras M; Kownator S; Minar E; Ostergren J; Poldermans D; Riambau V; Roffi M; Rother J; Sievert H; van Sambeek M; Zeller T; Avrupa Kardiyoloji Derneği ESC Periferik Atardamar; Avrupa Inme Organizasyonu (ESO) tarafindan destekl
Article: BMC MEDICAL EDUCATION. 2012;12:5
Does individual learning styles influence the choice to use a web-based ECG learning programme in a blended learning setting?
Nilsson M; Ostergren J; Fors U; Rickenlund A; Jorfeldt L; Caidahl K; Bolinder G
Article: EUROPEAN HEART JOURNAL. 2011;32(22):2851-2906
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)
Tendera M; Aboyans V; Bartelink M-L; Baumgartner I; Clement D; Collet J-P; Cremonesi A; De Carlo M; Erbel R; Fowkes FGR; Heras M; Kownator S; Minar E; Ostergren J; Poldermans D; Riambau V; Roffi M; Roether J; Sievert H; van Sambeek M; Zeller T; Bax J; Auricchio A; Baumgartner H; Ceconi C; Dean V; Deaton C; Fagard R; Funck-Brentano C; Hasdai D; Hoes A; Knuuti J; Kolh P; McDonagh T; Moulin C; Poldermans D; Popescu B; Reiner Z; Sechtem U; Sirnes PA; Torbicki A; Vahanian A; Windecker S; Agewall S; Blinc A; Bulvas M; Cosentino F; De Backer T; Gottsater A; Gulba D; Guzik TJ; Jonsson B; Kesmarky G; Kitsiou A; Kuczmik W; Larsen ML; Madaric J; Mas J-L; McMurray JJV; Micari A; Mosseri M; Muller C; Naylor R; Norrving B; Oto O; Pasierski T; Plouin P-F; Ribichini F; Ricco J-B; Ruilop L; Schmid J-P; Schwehr U; Sol BGM; Sprynger M; Tiefenbacher C; Tsioufis C; Van Damme H
Article: AMERICAN HEART JOURNAL. 2011;162(5):900-906
Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
Ariti CA; Cleland JGF; Pocock SJ; Pfeffer MA; Swedberg K; Granger CB; McMurray JJV; Michelson EL; Ostergren J; Yusuf S
Article: INTERNATIONAL ANGIOLOGY. 2011;30(2):150-155
The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia
Belch JJF; Ray S; Rajput-Ray M; Engeset J; Fagrell B; Lepantalo M; Mckay A; Mackay IR; Ostergren J; Ruckley CV; Salenius J
Journal article: AUSTRALASIAN EMERGENCY CARE. 2011;14:s21
Multitasking and interruptions of emergency department clinicians’ activities
Berg LM; Ehrenberg A; Östergren J; Florin J; Göransson KE
Journal article: AUSTRALASIAN EMERGENCY CARE. 2011;14:s18
Medical errors regarding emergency department care reported to national authorities in Sweden by care providers and patients
Källberg A-S; Ehrenberg A; Östergren J; Florin J; Göransson KE
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2010;44(6):325-330
Change in blood pressure during hospitalisation for acute heart failure predicts mortality
Svensson P; Sundberg H; Lund LH; Ostergren J
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2010;12(6):557-565
Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme
Hawkins NM; Wang D; Petrie MC; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Solomon SD; Ostergren J; Michelson EL; Pocock SJ; Maggioni AP; McMurray JJV
Article: JOURNAL OF INTERNAL MEDICINE. 2010;267(4):357-369
Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and women
Holzmann MJ; Ivert T; Jungner I; Nordqvist T; Walldius G; Ostergren J; Hammar N
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2009;11(11):1092-1098
Adherence to medication according to sex and age in the CHARM programme
Granger BB; Ekman I; Granger CB; Ostergren J; Olofsson B; Michelson E; McMurray JJV; Yusuf S; Pfeffer MA; Swedberg K
Article: JOURNAL OF INTERNAL MEDICINE. 2009;266(5):457-466
Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment
Malmstrom RE; Orstergren J; Jorgensen L; Hjemdahl P
Article: LAKARTIDNINGEN. 2009;106(38):2354-2356
[Variation of internship test results depends on the seat of learning and age. Analysis of tests 1995-2008].
Ostergren J; Kaviani C; Thorvaldsen T; Krook-Brandt M; Dahlgren L-O
Article: DIABETES CARE. 2009;32(5):915-920
Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program
Preiss D; Zetterstrand S; McMurray JJV; Ostergren J; Michelson EL; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; Gerstein HC; Sattar N
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2008;52(24):2000-2007
Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program
Meredith PA; Ostergren J; Anand I; Puu M; Solomon SD; Michelson EL; Olofsson B; Granger CB; Yusuf S; Swedberg K; Pfeffer MA; McMurray JJV
Article: JOURNAL OF HYPERTENSION. 2008;26(11):2103-2111
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes
Ostergren J; Poulter NR; Sever PS; Dahlof B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E
Article: EUROPEAN HEART JOURNAL. 2008;29(21):2641-2650
Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme
Pocock SJ; McMurray JJV; Dobson J; Yusuf S; Granger CB; Michelson EL; Oestergren J; Pfeffer MA; Solomon SD; Anker SD; Swedberg KB
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2008;102(6):733-737
Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Article: ATHEROSCLEROSIS. 2008;199(2):397-401
Cystatin C -: A marker of peripheral atherosclerotic disease?
Arpegard J; Oestergren J; de Faire U; Hansson L-O; Svensson P
Article: EUROPEAN HEART JOURNAL. 2008;29(11):1377-1385
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure
MacDonald MR; Petrie MC; Varyani F; Ostergren J; Michelson EL; Young JB; Solomon SD; Granger CB; Swedberg K; Yusuf S; Pfeffer MA; McMurray JJV
Article: BMC MEDICAL EDUCATION. 2008;8:25
Evaluation of a web-based ECG-interpretation programme for undergraduate medical students
Nilsson M; Bolinder G; Held C; Johansson B-L; Fors U; Ostergren J
Article: EUROPEAN HEART JOURNAL. 2008;29(4):499-508
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm:: extended observations 2 years after trial closure
Sever PS; Poulter NR; Dahlof B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes G; Mehlsen J; Nieminen MS; O'Brien ET; Ostergren J
Article: BLOOD PRESSURE. 2008;17(1):7-17
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension:: The ACCOMPLISH Study
Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlof B; Velazquez EJ; Gupte J; Staikos L; Hua TA; Shi V; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M
Article: CIRCULATION. 2007;115(24):3111-3120
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure - Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program
O'Meara E; Clayton T; McEntegart MB; McMurray JJV; Pina IL; Granger CB; Ostergren J; Michelson EL; Solomon SD; Pocock S; Yusuf S; Swedberg K; Pfeffer MA
Article: REVISTA ESPANOLA DE CARDIOLOGIA. 2007;60(5):1e-64e
[Guidelines on diabetes, pre-diabetes, and cardiovascular diseases].
Grupo de Trabajo sobre Diabetes y Enfermedades Car; Rydén L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer M-J; Cosentino F; Jönsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2007;9(5):510-517
Prevalence and prognostic impact of bundle branch block in patients with heart failure:: Evidence from the CHARM programme
Hawkins NM; Wang D; McMurray JJV; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG
Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2007;49(6):687-694
Diastolic dysfunction in heart failure with preserved systolic function:: Need for objective evidence -: Results from the CHARM echocardiographic Substudy CHARMES
Persson H; Lonn E; Edner M; Baruch L; Lang CC; Morton JJ; Ostergren J; McKelvie RS
Article: HEART. 2007;93(1):59-64
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure:: evidence from the CHARM programme
Hawkins NM; Wang D; McMurray JJV; Pfeffer MA; Swedberg K; Granger CB; Yusuf S; Pocock SJ; Ostergren J; Michelson EL; Dunn FG
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2007;27(1):30-35
Myocardial ischaemia in patients with peripheral arterial disease
Svensson P; de Faire U; Niklasson U; Ostergren J
Article: EUROPEAN HEART JOURNAL. 2006;27(12):1447-1458
Resource utilization and costs in the Candesartan in Heart failure:: Assessment of Reduction in Mortality and morbidity (CHARM) programme
McMurray JJV; Andersson FL; Stewart S; Svensson K; Solal AC; Dietz R; Vanhaecke J; van Veldhuisen DJ; Östergren J; Granger CB; Yusuf S; Pfeffer MA; Swedberg K
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2006;7:S1-S7
Clinical evidence for the cardiovascular benefits of angiotensin receptor Blockers
Nickenig G; Ostergren J; Struijker-Boudier H
Article: AMERICAN HEART JOURNAL. 2006;151(5):985-991
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the candesartan in heart failure:: Assessment of reduction in mortality and morbidity (CHARM)-Added trial
McMurray JJV; Young JB; Dunlap ME; Granger CB; Hainer J; Michelson EL; Earle S; Olofsson B; Östergren J; Yusuf S; Swedberg K; Pfeffer MA
Article: CIRCULATION. 2006;113(7):986-994
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure -: Results of the Candesartan in Heart Failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) Program
O'Meara E; Clayton T; McEntegart MB; McMurray JJV; Lang CC; Roger SD; Young JB; Solomon SD; Granger CB; Östergren J; Olofsson B; Michelson EL; Pocock S; Yusuf S; Swedberg K; Pfeffer MA
Article: CIRCULATION. 2006;113(5):671-678
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure
Hillege HL; Nitsch D; Pfeffer MA; Swedberg K; McMurray JJV; Yusuf S; Granger CB; Michelson EL; Östergren J; Cornel JH; de Zeeuw D; Pocock S; van Veldhuisen DJ
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2006;5(1):120
544 Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: a post‐hoc analysis of the CHARM‐Added trial
McMurray JJV; Granger CB; Michelson EL; Olofsson B; Ostergren J; Yusuf S; Swedberg K; Pfeffer MA; Investigators OBOTC
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2006;5(1):124
555 Indirect comparison of the effects of adding an aldosterone antagonist or an angiotensin receptor blocker in severe heart failure: new data from the CHARM‐Added trial
Weir RAP; McMurray JJV; Granger CB; Olofsson B; Ostergren J; Yusuf S; Swedberg K; Pfeffer MA; Investigators OBOTC
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2006;5(1):30
119 Blood pressure in acute heart failure: relation to mortality at follow up
Sundberg H; Svensson P; Ostergren J
Article: EUROPEAN HEART JOURNAL. 2006;27(1):65-75
Predictors of mortality and morbidity in patients with chronic heart failure
Pocock SJ; Wang DL; Pfeffer MA; Yusuf S; McMurray JJV; Swedberg KB; Östergren J; Michelson EL; Pieper KS; Granger CB
Article: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2005;294(14):1794-1798
Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure
Demers C; McMurray JJV; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Östergren J; Michelson EL; Johansson PA; Wang DL; Yusuf S
Article: THE LANCET. 2005;366(9489):907-913
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
Poulter NR; Wedel H; Dahlöf B; Sever PS; Beevers DG; Caulfield M; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Östergren J; Pocock S
Article: THE LANCET. 2005;366(9489):895-906
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Östergren J
Article: CIRCULATION. 2005;112(1):48-53
Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure.
Yusuf S; Ostergren JB; Gerstein HC; Pfeffer MA; Swedberg K; Granger CB; Olofsson B; Probstfield J; McMurray JV; Candesartan in Heart Failure-Assessment of Reducti
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2005;4(1):92
408 Incremental benefit of candesartan in heart failure ‐ new analyses of CHARM‐Added, according to baseline treatment
McMurray JJV; Ostergren J; Held P; Michelson EL; Olofsson B; Granger C; Yusuf S; Pfeffer MA; Swedberg K
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2005;7(4):650-656
Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
O'Meara E; Lewis E; Granger C; Dunlap ME; McKelvie RS; Probstfield JL; Young JB; Michelson EL; Ostergren J; Carlsson J; Olofsson B; McMurray J; Yusuf S; Swedberg K; Pfeffer MA
Article: DIABETES CARE. 2005;28(5):1151-1157
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes:: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)
Sever PS; Poulter NR; Dahlöf B; Wedel H; Collins R; Beevers G; Caulfield M; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Article: JOURNAL OF CARDIOVASCULAR RISK. 2005;12(1):75-81
Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial
Dagenais GR; Yi OL; Lonn E; Sleight P; Ostergren J; Yusuf S
Journal article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (EJPC). 2005;12(1):75-81
Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial
Dagenais GR; Yi Q; Lonn E; Sleight P; Ostergren J; Yusuf S
Article: BLOOD PRESSURE. 2005;14(2):99-106
Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease
Svensson P; De Faire U; Niklasson U; Hansson LO; Östergren J
Article: CIRCULATION. 2004;110(17):2618-2626
Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction - Results of the CHARM low-left ventricular ejection fraction trials
Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJV; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K
Article: JOURNAL OF HUMAN HYPERTENSION. 2004;18(3):193-200
Office blood pressure underestimates ambulatory blood pressure in peripheral arterial disease in comparison to healthy controls
Svensson P; de Faire U; Niklasson U; Östergren J
Article: EUROPEAN HEART JOURNAL. 2004;25(1):17-24
Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease
Östergren J; Sleight P; Dagenais G; Danisa K; Bosch J; Yi QL; Yusuf S
Article: THE LANCET. 2003;362(9386):777-781
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:: the CHARM-Preserved Trial
Yusuf S; Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJV; Michelson EL; Olofsson B; Östergren J
Article: THE LANCET. 2003;362(9386):772-776
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial
Granger CB; McMurray JJV; Yusuf S; Held P; Michelson EL; Olofsson B; Östergren J; Pfeffer MA; Swedberg K
Article: THE LANCET. 2003;362(9386):767-771
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
McMurray JJV; Östergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA
Article: THE LANCET. 2003;362(9386):759-766
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
Pfeffer MA; Swedberg K; Granger CB; Held P; McMurray JJV; Michelson EL; Olofsson B; Östergren J; Yusuf S
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2003;4(3):171-175
Angiotensin receptor blockers in heart failure
Östergren J; McMurray JJV
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2003;2(1):129
590 How do men and women with chronic heart failure differ? Baseline demographics from CHARM
McMurray J; Granger C; Held P; Olofsson B; Pfeffer M; Swedberg K; Yusuf S; Östergren J; Michelson E
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2003;2(1):130
594 Differences between diabetic and non‐diabetic patients with chronic heart failure. Baseline demographics from CHARM
Östergren J; Granger C; Held P; Olofsson B; Pfeffer M; McMurray J; Swedberg K; Yusuf S; Michelson E
Journal article: EUROPEAN JOURNAL OF HEART FAILURE, SUPPLEMENT. 2003;2(1):128
588 Differences between younger and older patients with chronic heart failure. Baseline demographics from CHARM
Swedberg K; Granger C; Held P; Olofsson B; McMurray J; Pfeffer M; Yusuf S; Östergren J; Michelson E
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2003;5(3):261-270
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure:: baseline characteristics of patients in the Candesartan in Heart failure -: Assessment of Reduction in Mortality and morbidity (CHARM) programme
McMurray J; Östergren J; Pfeffer M; Swedberg K; Granger C; Yusuf S; Held P; Michelson E; Olofsson B
Article: THE LANCET. 2003;361(9364):1149-1158
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Östergren J
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2002;22(6):370-374
Skin microvascular dilatation response to acetylcholine and sodium nitroprusside in peripheral arterial disease
Jägrén C; Gazelius B; Ihrman-Sandal C; Lindblad LE; Östergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2002;251(6):508-517
The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events:: a Swedish sub-study to the HOPE study
Björholt I; Andersson FL; Kahan T; Östergren J
Article: THE BMJ. 2002;324(7339):699-702
Use of ramipril in preventing stroke: double blind randomised trial
Bosch J; Yusuf S; Pogue J; Sleight P; Lonn E; Rangoonwala B; Davies R; Ostergren J; Probstfield J
Article: HYPERTENSION. 2001;38(6):E28-E32
Comparative effects of ramipril on ambulatory and office blood pressures -: A HOPE substudy
Svensson P; de Faire U; Sleight P; Yusuf S; Östergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2001;250(5):398-405
Episodes of ST-segment depression is related to changes in ambulatory blood pressure and heart rate in intermittent claudication
Svensson P; Niklasson U; Östergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2001;250(5):390-397
Asymptomatic versus symptomatic persistent atrial fibrillation:: clinical and noninvasive characteristics
Frykman V; Frick M; Jensen-Urstad M; Östergren J; Rosenqvist M
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2001;55(7):449-457
What is the relevance of the hope study in general practice?
Kennedy J; Mogensen CE; Ball SG; Castaigne AD; Commerford PJ; Distiller L; Fisher BM; Gonzalez-Jaunatey J; Nosadini R; Novials A; Östergren J; Palma-Gámiz J; Perrone-Filardi P; Schipperheijn JJ; Senges J; Trevisan R
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15:S11-S12
Anglo-Scandinavian Cardiac Outcomes Trial:: a brief history, rationale and outline protocol
Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Article: JOURNAL OF HYPERTENSION. 2001;19(6):1167-1176
Regression of left ventricular hypertrophy in human hypertension with irbesartan
Malmqvist K; Kahan T; Edner M; Held C; Hägg A; Lind L; Müller-Brunotte R; Nyström F; Öhman KP; Osbakken MD; Östergren J
Article: JOURNAL OF HYPERTENSION. 2001;19(6):1139-1147
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial
Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J
Article: CLINICAL CARDIOLOGY. 2001;24(3):238-244
Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation
Frick M; Frykman V; Jensen-Urstad M; Östergren J; Rosenqvist M
Article: JOURNAL OF HYPERTENSION. 2001;19(2):311-317
Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension
Malmqvist K; Isaksson H; Östergren J; Kahan T
Article: BLOOD PRESSURE. 2001;10(2):101-110
Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism
Malmqvist K; Kahan T; Isaksson H; Östergren J
Article: EUROPEAN HEART JOURNAL. 2000;21(14):1177-1185
The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation
Frick M; Darpo B; Östergren J; Rosenqvist M
Journal article: AMERICAN JOURNAL OF HYPERTENSION. 2000;13(S2):32a
Regression of left ventricular mass is not related to glucose and lipid metabolism in human hypertension
Malmqvist K; Kahan T; Isaksson H; Östergren J
Journal article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 2000;4(2):46
Cilostazol improved walking distances and was safe in patients with intermittent claudication
Östergren J
Article: BLOOD PRESSURE. 2000;9(6):340-345
Less difference between office and ambulatory blood pressure in women than in men both before and during antihypertensive treatment
Nyström FH; Öhman KP; Isaksson H; Schwan Å; Östergren J
Article: LAKARTIDNINGEN. 1999;96(48):5326-5327
[Is it time to reconsider the guidelines for hypertension therapy? Several new international recommendations published].
Ostergren J
Journal article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 1999;3(4):95
Patients with PVD had greater risks of major perioperative complications associated with myocardial revascularization than patients without PVD
Östergren J
Article: JOURNAL OF CARDIAC FAILURE. 1999;5(3):276-282
Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.
Swedberg K; Pfeffer M; Granger C; Held P; McMurray J; Ohlin G; Olofsson B; Ostergren J; Yusuf S
Article: AMERICAN JOURNAL OF CARDIOLOGY. 1999;84(1):104-A9
Effect of intravenous magnesium on heart rate and heart rate variability in patients with chronic atrial fibrillation
Frick M; Östergren J; Rosenqvist M
Article: DIABETES CARE. 1999;22(1):147-151
Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers
Kalani M; Brismar K; Fagrell B; Östergren J; Jörneskog G
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1998;32(5):753-759
Adrenaline responsiveness in mild hypertension:: No evidence for altered β-adrenoceptor sensitivity
Kahan T; Hjemdahl P; Lindvall K; Östergren J; de Faire U
Article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 1998;2(3):82
Urokinase reduced the need for open surgical procedures in acute ischemia of the leg.
Ostergren J
Article: LAKARTIDNINGEN. 1998;95(32-33):3380-3381
[New discoveries on target blood pressure and ACE inhibitors. Swedish guidelines on hypertension are still correct].
Ostergren J
Article: AMERICAN JOURNAL OF HYPERTENSION. 1998;11(6):690-696
Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension
Östergren J; Isaksson H; Brodin U; Schwan Å; Öhman KP
Article: JOURNAL OF HYPERTENSION. 1997;15(11):1327-1335
Main results of the losartan versus amlodipine (LOA) study on drug tolerability and psychological general well-being
Dahlof B; Lindholm LH; Carney S; Pentikainen PJ; Ostergren J
Article: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 1997;1(2):38
Ankle brachial index is a predictor of 5-year cardiovascular events.
Ostergren J
Article: BLOOD PRESSURE. 1996;5(1):41-49
Quality of life in hypertensive patients treated with either carvedilol or enalapril.
Ostergren J; Storstein L; Karlberg BE; Tibblin G
Journal article: LAKARTIDNINGEN. 1993;90(32-33):2653-2654
[Do ACE inhibitors potentiate snake venom? Severe and prolonged hypotension caused by adder bite].
Svensson P; Rosenberg J; Ostergren J; Karlson-Stiber C
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1989;8(3):237-244
SKIN CAPILLARY BLOOD-CELL VELOCITY IN PREECLAMPSIA - THE EFFECT OF PLASMA EXPANSION
ROSEN L; OSTERGREN J; FAGRELL B; STRANDEN E
Journal article: MICROVASCULAR RESEARCH. 1989;37(3):289-297
BILATERAL INVOLVEMENT AND THE EFFECT OF SYMPATHETIC BLOCKADE ON SKIN MICROCIRCULATION IN THE SYMPATHETIC DYSTROPHIES
ROSEN L; OSTERGREN J; ROALD OK; STRANDEN E; FAGRELL B
Journal article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1988;18(3):305-308
SKIN MICROVASCULAR CIRCULATION IN THE SYMPATHETIC DYSTROPHIES EVALUATED BY VIDEOPHOTOMETRIC CAPILLAROSCOPY AND LASER DOPPLER FLUXMETRY
ROSEN L; OSTERGREN J; FAGRELL B; STRANDEN E
Journal article: INTERNATIONAL ANGIOLOGY. 1988;7(1):37-41
EVALUATION OF A LASER DOPPLER MULTIPROBE FOR DETECTING SKIN MICROCIRCULATORY DISTURBANCES IN PATIENTS WITH OBLITERATIVE ARTERIOSCLEROSIS
OSTERGREN J; SCHOPS P; FAGRELL B
Journal article: DIABETES RES. 1987;5(4):189-192
Skin microvascular blood flow control in long duration diabetics with and without complications.
Tooke JE; Ostergren J; Lins PE; Fagrell B
Journal article: ACTA MEDICA SCANDINAVICA. 1986;220(5):485-488
ACRODERMATITIS CHRONICA ATROPHICANS HERXHEIMER CAN OFTEN MIMIC A PERIPHERAL VASCULAR DISORDER
FAGRELL B; STIERNSTEDT G; OSTERGREN J
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1986;5(1):37-51
SKIN CAPILLARY BLOOD-CELL VELOCITY IN MAN - CHARACTERISTICS AND REPRODUCIBILITY OF THE REACTIVE HYPEREMIA RESPONSE
OSTERGREN J; FAGRELL B
Journal article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1986;8:S119-S121
ADRENALINE RESPONSIVENESS IN BORDERLINE HYPERTENSION
HJEMDAHL P; LINDVALL K; KAHAN T; DEFAIRE U; OSTERGREN J
Journal article: VASA - EUROPEAN JOURNAL OF VASCULAR MEDICINE. 1986;15(1):56-60
PGE1 TREATMENT OF SEVERE SKIN ISCHEMIA IN PATIENTS WITH PERIPHERAL ARTERIAL INSUFFICIENCY - THE EFFECT ON SKIN MICROCIRCULATION
FAGRELL B; LUNDBERG G; OLSSON A; OSTERGREN J
Journal article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 1985;5(1):35-43
SKIN CAPILLARY BLOOD-CELL VELOCITY IN PATIENTS WITH ARTERIAL OBLITERATIVE DISEASE AND POLYCYTHEMIA - A DISTURBED REACTIVE HYPEREMIA RESPONSE
OSTERGREN J; FAGRELL B
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1985;4(3):249-256
SKIN MICROVASCULAR AUTOREGULATORY RESPONSES IN TYPE-I DIABETES - THE INFLUENCE OF DURATION AND CONTROL
TOOKE JE; LINS PE; OSTERGREN J; FAGRELL B
Journal article: ACTA PHYSIOLOGICA. 1984;121(2):165-171
THEOPHYLLINE ANTAGONIZES CARDIOVASCULAR-RESPONSES TO DIPYRIDAMOLE IN MAN WITHOUT AFFECTING INCREASES IN PLASMA ADENOSINE
SOLLEVI A; OSTERGREN J; FAGRELL B; HJEMDAHL P
Journal article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 1984;4(2):169-176
VIDEOPHOTOMETRIC CAPILLAROSCOPY FOR EVALUATING DRUG EFFECTS ON SKIN MICROCIRCULATION - A DOUBLE-BLIND-STUDY WITH NIFEDIPINE
OSTERGREN J; FAGRELL B
Journal article: ACTA MEDICA SCANDINAVICA, SUPPLEMENT. 1984;687:25-28
VITAL CAPILLARY MICROSCOPY FOR ASSESSMENT OF SKIN VIABILITY AND MICROANGIOPATHY IN PATIENTS WITH DIABETES-MELLITUS
FAGRELL B; HERMANSSON IL; KARLANDER SG; OSTERGREN J
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1983;2(4):277-284
SYNCHRONOUS ASSESSMENT OF HUMAN-SKIN MICROCIRCULATION BY LASER DOPPLER FLOWMETRY AND DYNAMIC CAPILLAROSCOPY
TOOKE JE; OSTERGREN J; FAGRELL B
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1983;2(4):315-324
THE INFLUENCE OF VENOUS AND ARTERIAL-OCCLUSION ON CAPILLARY BLOOD-FLOW AND TRANS-CUTANEOUS OXYGEN-TENSION IN FINGERS
OSTERGREN J; SVEDMAN P; FAGRELL B
Journal article: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 1982;13(Suppl 2):S233-S235
EFFECT OF INTRAVENOUSLY ADMINISTERED PINDOLOL ON SKIN CAPILLARY BLOOD-CELL VELOCITY IN FINGERS
FAGRELL B; OSTERGREN J
Journal article: INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL. 1982;1(2):163-171
THE INFLUENCE OF HYDROSTATIC-PRESSURE AND CONTRALATERAL COOLING ON CAPILLARY BLOOD-CELL VELOCITY AND TRANS-CUTANEOUS OXYGEN-TENSION IN FINGERS
FAGRELL B; SVEDMAN P; OSTERGREN J
Journal article: MICROVASCULAR RESEARCH. 1980;20(3):327-335
RELATIVE HEMATOCRIT IN HUMAN-SKIN CAPILLARIES AND ITS RELATION TO CAPILLARY BLOOD-FLOW VELOCITY
FAGRELL B; INTAGLIETTA M; OSTERGREN J
Visa fler

Alla övriga publikationer

Corrigendum: EUROPEAN HEART JOURNAL. 2014;35(27):1824
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD (vol 34, pg 3035, 2013)
Ryden L; Grant PJ; Anker SD; Berne C; Cosentino F; Danchin N; Deaton C; Escaned J; Hammes H-P; Huikuri H; Marre M; Marx N; Mellbin L; Ostergren J; Patrono C; Seferovic P; Uva MS; Taskinen M-R; Tendera M; Tuomilehto J; Valensi P; Zamorano JL
Review: EUROPEAN HEART JOURNAL. 2013;34(28):2159-2219
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Mancia G; Fagard R; Narkiewicz K; Redon J; Zanchetti A; Böhm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Redon J; Dominiczak A; Narkiewicz K; Nilsson PM; Burnier M; Viigimaa M; Ambrosioni E; Caufield M; Coca A; Olsen MH; Schmieder RE; Tsioufis C; van de Borne P; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Clement DL; Coca A; Gillebert TC; Tendera M; Rosei EA; Ambrosioni E; Anker SD; Bauersachs J; Hitij JB; Caulfield M; De Buyzere M; De Geest S; Derumeaux GA; Erdine S; Farsang C; Funck-Brentano C; Gerc V; Germano G; Gielen S; Haller H; Hoes AW; Jordan J; Kahan T; Komajda M; Lovic D; Mahrholdt H; Olsen MH; Ostergren J; Parati G; Perk J; Polonia J; Popescu BA; Reiner Z; Rydén L; Sirenko Y; Stanton A; Struijker-Boudier H; Tsioufis C; van de Borne P; Vlachopoulos C; Volpe M; Wood DA
Review: LAKARTIDNINGEN. 2012;109(36):1544-1548
[Hypertension is a clinical problem ... even though we have tools to solve it].
Ostergren J
Letter: THROMBOSIS RESEARCH. 2010;125(5):473-474
Poor performance with a platelet counting technique to monitor clopidogrel inhibitory effects in the point-of-care setting
Malmstrom RE; Ostergren J; Jorgensen L; Hjemdahl P
Review: THE JOURNAL OF CLINICAL HYPERTENSION. 2009;11(2):66-73
Where Are We With the Management of Hypertension? From Science to Clinical Practice
Farsang C; Naditch-Brule L; Avogaro A; Oestergren J; Verdecchia P; Maggioni A; van de Borne P; Lins R; Roca-Cusachs A
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2008;9(1):205
LIPID LOWERING EFFICACY OF ROSUVASTATIN VS ATORVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
Ostergren J; Malmstrom R; Jorgensen L; Walldius G
Review: EUROPEAN HEART JOURNAL, SUPPLEMENT. 2007;9(C):C3-C74
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text
Ryden L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer M-J; Cosentino F; Jonsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Qiao Q; Priori SG; Blanc J-J; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Luis Zamorano J; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; GohIke H; Gonzalez Juanatey JR; Graham I; Monteiro PF; Parhofer K; Pyorala K; Raz I; Schernthaner G; Volpe M; Wood D
Published conference paper: DIABETES RESEARCH AND CLINICAL PRACTICE. 2007;76:S13-S21
Renin-angiotensin-system blockade in the prevention of diabetes
Ostergren J
Editorial comment: DIABETES RESEARCH AND CLINICAL PRACTICE. 2007;76:S1-S2
Angiotensin receptor blockers in the prevention and management of diabetes and its complications -: Introduction
Ostergren J
Review: EUROPEAN HEART JOURNAL. 2007;28(1):88-136
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary - The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Ryden L; Standl E; Bartnik M; Van den Berghe G; Betteridge J; de Boer M-J; Cosentino F; Jonsson B; Laakso M; Malmberg K; Priori S; Ostergren J; Tuomilehto J; Thrainsdottir I; Vanhorebeek I; Stramba-Badiale M; Lindgren P; Priori SG; Blanc J-J; Budaj A; Camm J; Dean V; Deckers J; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo J; Zamorano JL; Deckers JW; Bertrand M; Charbonnel B; Erdmann E; Ferrannini E; Flyvbjerg A; Gohlke H; Juanatey JRG; Graham I; Monteiro PF; Parhofer K; Pyorala K; Raz I; Schernthaner G; Volpe M; Wood D
Review: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2006;7(2):64-73
From hypertension to heart failure -: Are there better primary prevention strategies?
Meredith PA; Oestergren J
Published conference paper: JOURNAL OF HYPERTENSION, SUPPLEMENT. 2006;24(1):S3-S7
Angiotensin receptor blockade with candesartan in heart failure:: findings from the Candesartan in Heart failure -: Assessment of Reduction in Mortality and morbidity (CHARM) programme
Ostergren JB
Meeting abstract: JOURNAL OF CARDIAC FAILURE. 2004;10(4):S76
Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: Results of the CHARM low
Young JB; Swedberg K; Dunlap ME; Pfeffer MA; Probstfield JL; Granger CB; McKelvey RS; McMurray MJV; Michaelson EL; Olofsson B; Ostergren J; Yusuf S
Review: EXPERT OPINION ON PHARMACOTHERAPY. 2004;5(7):1589-1597
Candesartan for the treatment of hypertension and heart failure
Östergren J
Meeting abstract: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2004;43(5):a473
Impact of the angiotensin-receptor blocker candesartan in preventing diabetes in patients with heart failure
Yusuf S; Ostergren JB; Gerstein H; Pfeffer MA; Swedberg K; Granger CB; McMurray JJV
Published conference paper: DRUGS. 2004;64:43-60
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial -: Lipid lowering arm (ASCOT-LLA):: A multicentre randomised controlled trial
Sever PS; Dahlöf B; Poulter NR; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Östergren J
Letter: HYPERTENSION. 2003;41(4):E5
Response:: HOPE not HYPE but mechanisms can be discussed
Svensson P; Östergren J
Editorial comment: EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY. 2002;24(1):4-5
Is there a need for the medical angiologist?
Östergren J; Fagrell B
Published conference paper: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2001;(117):19-21
Pharmaeoeconomic impact of HOPE
Östergren JB; Björholt I; Andersson F; Kahan T
Review: LAKARTIDNINGEN. 1999;96(13):1585-1590
[Intermittent claudication--a major cardiovascular risk factor. Proposed guidelines for investigation and treatment].
Svensson P; Wahlberg E; Hedin U; Ostergren J
Editorial comment: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 1998;:2
The role of ACE inhibitors in the prevention and treatment of atherosclerosis: a clinical approach - Introduction
Ostergren J
Visa fler

Anställningar

Projektledare, Lärande, Informatik, Management och Etik, Karolinska Institutet, 2024-2024

Examina och utbildning

Docent, Karolinska Institutet, 1988

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI